Moe GW - Search Results

1

N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study.

Moe GW, Howlett J, Januzzi JL, Zowall H; Canadian Multicenter Improved Management of Patients With Congestive Heart Failure (IMPROVE-CHF) Study Investigators. Moe GW, et al. Circulation. 2007 Jun 19;115(24):3103-10. doi: 10.1161/CIRCULATIONAHA.106.666255. Epub 2007 Jun 4. Circulation. 2007. PMID: 17548729 Clinical Trial.

2

Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentration.

Moe GW, Grima EA, Angus C, Wong NL, Hu DC, Howard RJ, Armstrong PW. Moe GW, et al. Circulation. 1991 May;83(5):1780-7. doi: 10.1161/01.cir.83.5.1780. Circulation. 1991. PMID: 1827057

3

Response of atrial natriuretic factor to postural change in patients with heart failure versus subjects with normal hemodynamics.

Moe GW, Canepa-Anson R, Howard RJ, Armstrong PW. Moe GW, et al. J Am Coll Cardiol. 1990 Sep;16(3):599-606. doi: 10.1016/0735-1097(90)90349-t. J Am Coll Cardiol. 1990. PMID: 2143766 Free article.

4

Medical advances in the treatment of congestive heart failure.

Armstrong PW, Moe GW. Armstrong PW, et al. Among authors: moe gw. Circulation. 1993 Dec;88(6):2941-52. doi: 10.1161/01.cir.88.6.2941. Circulation. 1993. PMID: 7902784 Review.

5

Dual natriuretic peptide system in experimental heart failure.

Moe GW, Grima EA, Wong NL, Howard RJ, Armstrong PW. Moe GW, et al. J Am Coll Cardiol. 1993 Sep;22(3):891-8. doi: 10.1016/0735-1097(93)90208-i. J Am Coll Cardiol. 1993. PMID: 8354829 Free article.

6

Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure.

Moe GW, Grima EA, Wong NL, Howard RJ, Armstrong PW. Moe GW, et al. J Am Coll Cardiol. 1996 Mar 1;27(3):720-7. doi: 10.1016/0735-1097(95)00504-8. J Am Coll Cardiol. 1996. PMID: 8606288 Free article.

7

Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan.

Moe GW, Rouleau JL, Charbonneau L, Proulx G, Arnold JM, Hall C, de Champlain J, Barr A, Sirois P, Packer M. Moe GW, et al. Am Heart J. 2000 Apr;139(4):587-95. doi: 10.1016/s0002-8703(00)90035-8. Am Heart J. 2000. PMID: 10740139 Clinical Trial.

8

BNP in the diagnosis and risk stratification of heart failure.

Moe GW. Moe GW. Heart Fail Monit. 2005;4(4):116-22. Heart Fail Monit. 2005. PMID: 16234898 Review.

9

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.

Arnold JM, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, Heckman GA, Howlett JG, Ignaszewski A, Johnstone DE, Jong P, McKelvie RS, Moe GW, Parker JD, Rao V, Ross HJ, Sequeira EJ, Svendsen AM, Teo K, Tsuyuki RT, White M; Canadian Cardiovascular Society. Arnold JM, et al. Among authors: moe gw. Can J Cardiol. 2006 Jan;22(1):23-45. doi: 10.1016/s0828-282x(06)70237-9. Can J Cardiol. 2006. PMID: 16450016 Free PMC article.

10

B-type natriuretic peptide in heart failure.

Moe GW. Moe GW. Curr Opin Cardiol. 2006 May;21(3):208-14. doi: 10.1097/01.hco.0000221582.71619.84. Curr Opin Cardiol. 2006. PMID: 16601459 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page